ESC 24: Hot Line & Late-breaking Science Video Collection
-
3m 52sPart 4 | Session 6 NOTION-3: FFR Guided PCI in TAVI
-
6m 48sPart 4 | Session 7 EPIC-CAD: Edoxaban vs Dual Antiplatelet Therapy in AF & CAD
-
8m 17sPart 4 | Session 8 SENIOR RITA: Invasive Vs Conservative Strategy for Older Patients with MI
-
3m 51sPart 4 | Session 9 EARTH-STEMI: Complete Vs Culprit-Only Revascularization in Older Patients
-
4m 17sPart 4 | Session 10 SCOFF: Fasting vs. Non-Fasting: Impact on Cardiac Catheterization Outcomes
-
4m 17sPart 4 | Session 11 GUARD-AF: Atrial Fibrillation Screening to Reduce Stroke in Elderly Individuals
-
2m 31s
-
7m 9sPart 4 | Session 13 POPular PAUSE TAVI: Continuation or interruption of OAC During TAVI
-
4m 54sPart 5 | Session 1 3 Trials That Will Change My Practice With Dr Muthiah Vaduganathan
-
13m 47sPart 5 | Session 2 3 Trials That Will Change My Practice With Dr Michelle Kittleson
-
6m 55sPart 6 | Session 1 New Guidelines for the Management of Atrial Fibrillation
-
6m 13sPart 6 | Session 2 New Guidelines for the Management of Aortic Diseases
-
47m 31sPart 1 | Session 1 ESC Congress 2024 Hot Line Wrap Up
-
27m 27sPart 1 | Session 2 ESC Congress 2024 Hot Line Preview
-
17m 25sPart 2 | Session 1 ESC Day 1 Wrap Up: New Guidelines, HELIOS-B, ABYSS & STOP-or-NOT
-
23m 2sPart 2 | Session 2 ESC Day 2 Wrap-Up: NOTION-3, RESHAPE-HF2, TRI.Fr & More
-
12m 28sPart 2 | Session 3 Day 3 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
-
15m 45sPart 2 | Session 4 Day 4 Wrap-Up: OCCUPI, REC-CAGEFREE I, AEGIS-II & More
-
20m 58sPart 3 | Session 1 AβYSS: Beta Blocker Interruption After Uncomplicated MI
-
20m 14sPart 3 | Session 2 RHEIA: TAVR vs SAVR in Women with Severe AS
-
8m 47sPart 3 | Session 3 OCEANIC-AF: Asundexian Vs Apixaban in Atrial Fibrillation
-
9m 29sPart 3 | Session 4 SWEDEGRAFT: No-touch Vein Graft in CABG
-
17m 28sPart 3 | Session 5 FINEARTS-HF: Finerenone HFmEF & HFpEF
-
6m 8s
-
5m 29sPart 4 | Session 2 MATTERHORN: M-TEER vs Surgery in Heart Failure
-
5m 46sPart 4 | Session 3 MRAs in Heart Failure
-
4m 24sPart 4 | Session 4 FINE-HEART: Finerenone in HF & CKD
ESC Congress 2024 — Improved patient-level adherence to guideline recommendations on heart rhythm control through healthcare professional education in patients with atrial fibrillation.
Investigator, Dr Dipak Kotecha (University of Birmingham, UK) joins us in London to share key findings from the STEEER-AF study (NCT04396418).
This prospective, cluster-randomized international study compared two groups of healthcare professionals caring for atrial fibrillation (AF) patients. One group receives a 16-week training program on stroke prevention and rhythm control, while the other receives no extra training. The researchers will follow 1750 patients from 70 different healthcare centers for 18 months to see if the training improves patient outcomes, particularly stroke prevention.
Findings showed no significant improvement in guideline adherence for stroke prevention, however, a significant 51% improvement was observed in guideline adherence for rhythm control. There was also significant improvement in a patient-reported secondary outcome which evaluated eight domains of integrated AF management.
Interview Questions:
- What is the background of STEEER-AF?
- Can you tell me more about the training provided in the intervention arm?
- What was the study design and methodology?
- What are your findings? Did you observe any differences between healthcare systems?
- What were some of the challenges in this study?
- What are the take-home messages?
Recorded on-site at ESC Congress 2024, London.
Editors: Jordan Rance and Mirjam Boros.
Videographers: Mike Knight, Dan Brent, Oliver Miles, Tom Green, David-Ben-Harosh.
Support: This is an independent interview produced by Radcliffe Cardiology.
What's hot at the ESC Congress 2024?
Stay ahead of the curve with our faculty-led coverage of the European Society of Cardiology Congress in London. From groundbreaking trials to expert insights, we've got you covered.
- Watch our View From the Thoraxcenter series for practice-focused reviews of the most anticipated trials from interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen.
- For a deeper dive into key hot line clinical trial data and its applicability, host, Dr Harriette Van Spall meets with principal investigators in her Late-Breaker Discussion series.
- View a condensed summary of the crucial takeaways from each day in our Wrap-Up series led by Dr Mirvat Alasnag.
- Our short, bite-sized Expert Interviews with select faculty will focus on data, take-home messages for practice and the future of their field.
Get ready for a deep dive into the latest cardiology research. Our coverage of the ESC Congress is coming soon.
More from this programme
Part 1
View From the Thoraxcenter: What's Hot at ESC 24?
Part 2
Daily Wrap Ups with Dr Alasnag and Dr Al-Shaibi
Part 3
Hot-line Discussions with Dr Harriette Van Spall
Part 4
Expert Interviews
Part 5
Highlights
Part 6
Guidelines
Faculty Biographies
Dipak Kotecha
Professor of Cardiology & Cardiac Imaging and Consultant Cardiologist
Dipak Kotecha is a Professor of Cardiology at the University of Birmingham, and a Consultant Cardiologist specialising in cardiac imaging. He has completed a prestigious National Institute for Health Research (NIHR) Fellowship and was awarded the British Cardiovascular Society, Michael Davies Medal, in 2018 for his contribution to cardiovascular medicine. He works extensively across the European Society of Cardiology (ESC) in education, trials and guidelines, and his research focuses on the interaction of heart failure and atrial fibrillation, supported by grants from the NIHR, British Heart Foundation and the European Union. Dipak leads international collaborations, with interests in patient involvement, big data approaches, the application of artificial intelligence, and the use of novel technology (the cardAIc group). He is passionate about innovative yet pragmatic trial design and healthcare-embedded approaches to improve patient care – this includes the…
Comments